Background: Sensing of muramyl dipeptide (MDP) is impaired in Crohn's disease (CD) patients with disease-linked variants of the CARD15 (caspase activation and recruitment domain 15) gene. Animal studies suggest that normal CARD15 signalling prevents inflammatory bowel disease, and may be important for disease development in CD. However, only a small fraction of CD patients carry the disease linked CARD15 variants. The aim of this study was thus to investigate if changes could be found in CARD15 signalling in patients without disease associated CARD15 variants.
Methodology/principal Findings: By mapping the response to MDP in peripheral monocytes obtained from CD patients in remission not receiving immunosuppresives, an impaired response to MDP was found in patients without disease linked CARD15 variants compared to control monocytes. This impairment was accompanied by a decreased activation of IkappaB kinase alpha/beta (IKKalpha/beta), the initial step in the nuclear factor kappaB (NFkappaB) pathway, whereas activation of mitogen-activated protein (MAP)-kinases was unaffected. MDP additionally stimulates the inflammasome which is of importance for processing of cytokines. The inflammasome was constitutively activated in CD, but unresponsive to MDP both in CD and control monocytes.
Conclusions/significance: These results suggest that inhibited MDP-dependent pathways in CD patients not carrying the disease-associated CARD15 variants might be of importance for the pathogenesis of CD. The results reveal a dysfunctional immune response in CD patients, not able to sense relevant stimuli on the one hand, and on the other hand possessing constitutively active cytokine processing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771351 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007794 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
NOD2 Polymorphisms May Direct a Crohn Disease Phenotype in Patients With Very Early-Onset Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
December 2023
From the Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.
Article Synopsis
- - NOD2/CARD15 is known as a key gene for Crohn's disease, especially in adult cases, and its genetic variations are linked to pediatric Crohn's as well.
- - In a study comparing 10 pediatric patients with NOD2 variations (NOD2 +) to 16 without (NOD2 -), the NOD2 + group showed significantly higher instances of Crohn's-like symptoms, stunted growth, and joint issues.
- - The results suggest that NOD2 polymorphisms could lead to specific health challenges in very early-onset inflammatory bowel disease, indicating the need for further research to inform targeted treatments.
A Chinese girl of Blau syndrome with renal arteritis and a literature review.
Pediatr Rheumatol Online J
March 2023
Department of Rheumatology, National Children's Medical Center, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, People's Republic of China.
Background: Blau syndrome is a rare autoinflammatory disease caused by autosomal dominant mutations in the CARD15/NOD2 gene. Vascular involvement is a rare phenotype in Blau syndrome patients. In this study, we aimed to describe a 20-year- old Chinese girl with Blau syndrome complicated by renal arteritis.
View Article and Find Full Text PDFBlau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Front Immunol
October 2022
Mucosal Immunity Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Article Synopsis
- The studies analyze how mutations in the NOD2 gene contribute to Blau syndrome by disrupting its normal signaling pathways, particularly affecting NF-κB activation and cross-regulation of innate immune responses.
- Key findings indicate that Blau-associated NOD2 mutations lead to impaired signaling, causing a loss of NOD2's ability to regulate inflammation effectively, which is vital in both Blau syndrome and Crohn's disease.
- The research suggests that the malfunctioning NOD2 signaling may be due to insufficient activation of the regulatory factor IRF4, which exacerbates inflammation in Blau syndrome.
Blau syndrome: a case report from Palestine.
Pediatr Rheumatol Online J
August 2021
Public Health Department, Faculty of Medicine and Health Sciences, An-Najah National University, P.O.Box:7, Nablus, Palestine.
Background: This case study documents the first familial case of Blau syndrome (BS) in Palestine characterized with mutation in CARD15/NOD2.
Case Presentation: Eighteen years old female was initially misdiagnosed with Juvenile idiopathic arthritis (JIA). The patient had been on steroids and methotrexate treatment for the last 16 years, but did not respond well to treatment.
Detection of mutations in gene in Arab patients with Crohn's disease.
Saudi J Gastroenterol
October 2021
Department of Research Core Facility, OMICS Research Unit, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Article Synopsis
- - The study investigates the connection between mutations in the NOD2/CARD15 gene and Crohn's disease (CD) among Arabs in Kuwait, focusing on four specific mutations.
- - Researchers analyzed DNA from 103 CD patients and 100 control subjects, discovering that mutations Pro268Ser (SNP5) and Gly908Arg (SNP12) showed differing associations with CD risk.
- - Results revealed that the Gly908Arg mutation increases susceptibility to CD, while the Pro268Ser mutation appears to provide some protective effect against the disease.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!